Professional
Added to YB: 2025-05-28
Pitch date: 2025-03-31
VETO.PA [neutral]
Vetoquinol SA
+1.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
Market Cap
EUR 861.1M
Pitch Price
EUR 76.88
Price Target
85.00 (+9%)
Dividend
N/A
EV/EBITDA
6.41
P/E
14.32
EV/Sales
1.31
Sector
Pharmaceuticals
Category
value
Show full summary:
The Gabelli Pet Parent's Fund Portfolio Holding: Vetoquinol SA
VETO.PA (earnings update): Global animal health pharma co specializing in vet products. Notable products: Phovia light therapy & Zylkene calming supplement. Generated significant 2024 cash flow via margin expansion & product mix improvements. PMV of €85 vs current €77.80.
Read full article (1 min)